Category: biology
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test. The test’s approval is another step forward for precision therapies that rely on…
Read More
Curative received FDA emergency use authorization for its novel COVID-19 tests
The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests have already been used by the City of Los Angeles since late March and have tested over 53,000 city residents.…
Read More
Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test
SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. The study, published in Nature, shows performance on par with existing PCR-based molecular tests, the one ones currently authorized for use by…
Read More
Microsoft hopes its ‘Planetary Computer’ will preserve biodiversity
Earlier this year, Microsoft announced that it plans to be carbon negative by 2030. The company hopes to help other organizations, researchers and governments improve the environment as well, with its “Planetary Computer” project. The initiative is m… Source
Read More
Pinterest CEO and a team of leading scientists launch a self-reporting COVID-19 tracking app
There have been a few scattered efforts to leverage crowd-sourced self-reporting of symptoms as a way to potentially predict and chart the progress of COVID-19 across the U.S., and around the world. A new effort looks like the most comprehensive, well-organized and credibly backed yet — and it has been…
Read More
Aspen Neuroscience raises $70 million for its experimental Parkinson Disease treatment
Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for Parkinson Disease. Now, eight years later, Aspen Neuroscience, the company she founded to bring her research to market has raised…
Read More